Phase I Testing of a Malaria Vaccine Composed of Hepatitis B Virus Core Particles Expressing Plasmodium falciparum Circumsporozoite Epitopes

Παρόμοια τεκμήρια

• Phase I Trial of an Alhydrogel Adjuvanted Hepatitis B Core Virus-Like Particle Containing Epitopes of Plasmodium falciparum Circumsporozoite Protein
  ανά: Gregson, Aric L., κ.ά.
  Έκδοση: (2008)
• A Linear Peptide Containing Minimal T- and B-Cell Epitopes of Plasmodium falciparum Circumsporozoite Protein Elicits Protection against Transgenic Sporozoite Challenge
  ανά: Calvo-Calle, J. Mauricio, κ.ά.
  Έκδοση: (2006)
• Imaging effector functions of human cytotoxic CD4+ T cells specific for Plasmodium falciparum circumsporozoite protein
  ανά: Frevert, Ute, κ.ά.
  Έκδοση: (2008)
• Safety and Enhanced Immunogenicity of a Hepatitis B Core Particle Plasmodium falciparum Malaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I Trial
  ανά: Oliveira, Giane A., κ.ά.
  Έκδοση: (2005)
• A Modified Hepatitis B Virus Core Particle Containing Multiple Epitopes of the Plasmodium falciparum Circumsporozoite Protein Provides a Highly Immunogenic Malaria Vaccine in Preclinical Analyses in Rodent and Primate Hosts
  ανά: Birkett, A., κ.ά.
  Έκδοση: (2002)